title: [Development of competitive enzyme immunoassay for the detection of influenza A(H5) virus antibodies].
abstract: An indirect enzyme immunoassay (EIA) using the purified fraction of surface viral glycoproteins (GP) as an antigen for solid phase sensitization was not shown to be a specific method for the differential detection of influenza A(HS) (HS-Ab) virus antibodies (Abs) due to total conservative epitopes in the structure of GPs of influenza A(H5) and A(H1NI) viruses. The cross activity of some monoclonal Abs (MAbs) to influenza A(H5) and A(HIN1) viruses, which had been obtained at the Research Institute of Influenza, was proof of the presence of total immunodominant determinants in the structure of influenza H1 and H5 virus hemagglutinin (HA). In this connection, an EIA, which was based on the competition of influenza A(H5) H5-Ab virus HA-specific MAbs in the test sera for an association with influenza A(H5) virus, was proposed for the subtype-specific detection of H5 Ab. Comparison of the results of competitive EIA (cEIA), microneutralization (MN) test and HA inhibition test (HAIT) (using equine red blood cells) in the examination of sera obtained from 44 volunteers immunized with inactivated vaccine containing influenza A/Indonesia/5/2005 (H5N1) virus showed the high sensitivity and specificity of cEIA in detecting H5-specific Abs. The effectiveness of cEIA for the sera strictly positive for the content of H5 Abs was close to that of MN test and was 9-34% higher than HAIT (depending on those used in the analysis of H5 virus antigens). cEIA may be proposed to assess new influenza vaccines as an additional laboratory test. Since the infectious virus is not used during cEIA, it may be recommended for the serodiagnosis of influenza A(H5) at practical virological laboratories.
authors.forename: V Z
authors.initials: VZ
authors.lastname: Krivitskaia
authors.forename: N V
authors.initials: NV
authors.lastname: Tret'iakova
authors.forename: E V
authors.initials: EV
authors.lastname: Sorokin
authors.forename: T R
authors.initials: TR
authors.lastname: Tsareva
authors.forename: T D
authors.initials: TD
authors.lastname: Smirnova
authors.forename: E M
authors.initials: EM
authors.lastname: Voĭtsekhovskaia
authors.forename: V S
authors.initials: VS
authors.lastname: Vakin
authors.forename: E V
authors.initials: EV
authors.lastname: Kuznetsova
authors.forename: A A
authors.initials: AA
authors.lastname: Vasil'eva
authors.forename: N A
authors.initials: NA
authors.lastname: Medvedeva
authors.forename: V G
authors.initials: VG
authors.lastname: Maĭorova
authors.forename: A A
authors.initials: AA
authors.lastname: Sominina
mesh_terms: D000911:Antibodies, Monoclonal / Q000276:immunology; D000914:Antibodies, Viral / Q000097:blood*; D000956:Antigens, Viral / Q000276:immunology; D003937:Diagnosis, Differential; D006801:Humans; D007124:Immunoenzyme Techniques / Q000379:methods*; D053124:Influenza A Virus, H5N1 Subtype / Q000276:immunology*; D007251:Influenza, Human / Q000821:virology*; D012680:Sensitivity and Specificity
chemical_list: D000911:Antibodies, Monoclonal; D000914:Antibodies, Viral; D000956:Antigens, Viral